Dickinson Andrew D bought GILD
February 12, 2025 · Form 4 insider transaction
Dickinson Andrew D bought 26,175 shares of Gilead Sciences, Inc. at $57.92 per share, a transaction worth $1.52M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26,175
Price
$57.92
Total value
$1.52M
InsiderDickinson Andrew D
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 12, 2025
Filing dateFebruary 13, 2025
Shares owned after275,089
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.